veronapharma.com (VRNA): Operatsion rentabellik

Ommaviy kompaniya Verona Pharma PLC (VRNA) logotipi

Operatsion marja vaqtlar ketma-ketligi Verona Pharma plc (VRNA) qimmatga tushadigan tadqiqotlar yakunlanganidan so'ng Ohtuvayre sotuvlarini kengaytirishga o'tayotganini ko'rsatadi, bunda ushbu ko'rsatkich hozirda -25.20 darajasida turibdi. Yetakchi pulmonologlar bilan hamkorlikka asoslangan xavflarni kamaytirish strategiyasi, tibbiy yordamga bo'lgan elastik bo'lmagan talab bilan birgalikda, kompaniyaga har qanday iqtisodiy tebranishlarga qarshi barqarorlikni ta'minlaydi.

VRNA: Verona Pharma PLC Operatsion marja 04.07.2022 - 18.10.2025

Verona Pharma plc (VRNA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Verona Pharma PLC, VRNA
Verona Pharma Inc. asosiy tovari

Verona Pharma plc (VRNA) uchun respirator dori vositalarini tijoratlashtirishning muvaffaqiyati bevosita AQSh va Buyuk Britaniyada ishlab chiqarishning xarajatlar samaradorligi bilan belgilanadi. Operatsion daromadning tushumga nisbati sifatida hisoblanadigan operatsion marja, moliyaviy majburiyatlar hisobga olinishidan oldin topilgan har bir dollardan sof daromadning ulushini ko'rsatadi. Operatsion marja grafigini tahlil qilish orqali investor biznesning yashirin yomonlashuvini tezda aniqlashi va qiymat tuzog'idan qochishi mumkin.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion marja MENS|Ligand Pharmaceuticals - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Amneal AMRX|Operatsion foyda bo'yicha marjinallik Perrigo Company PLC|Alvotech Biopharmaceuticals - Operatsion marja|Operatsion faoliyat rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operatsion rentabellik|anipharmaceuticals.com - Operatsion foyda normasi|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.